Pfizer's stock has been trading at low levels for a while. Diminished growth and concerns about the future have investors ...

In a gripping new release from Skyhorse Publishing, molecular biologist and whistleblower Becky McClain lays bare her harrowing journey in "Exposed," a book that promises to shake the foundations of ...

Pfizer (PFE) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the ...

Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...

Pfizer (PFE) offers potential 20-30% upside despite revenue risks. Explore its valuation, pipeline prospects, and dividend ...

President Donald Trump’s new partnership with Pfizer to sell drugs directly to consumers is being cast as a major ...

U.S. Investment Forum 2025, a renowned era that has significantly unfolded the relationship between the Kingdom of Saudi ...

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Korea Post Marketing Surveillance (PMS) Study ...

Pfizer Inc. is a global biopharmaceutical leader with a diversified product portfolio and significant scale, supported by ...

He stipulated that the honoree should be a force for good, and selected Pfizer Chairman Albert Bourla for his innovation, ...

Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 19, Pfizer Inc. (NYSE:PFE ...